Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trimlife acquired

This article was originally published in The Tan Sheet

Executive Summary

Neutraceutical Company says it acquired nutritional supplement company Trimlife to introduce wellness products and services on an "aggressive" timetable with a concentration on quality and safety. "Our expansion will focus on healthy, organic, natural aids to common issues affecting many of us," the Fort Lee, N.J.-based firm says Jan. 30. New initiatives include a seven-step wellness program. The firm recently introduced Lipitone Advanced, a weight-loss brand that contains fat-blocking and carb-loading herbal ingredients and increases energy levels, the firm claim

You may also be interested in...

Supplements’ Direct Response Marketing Success Sets Off FTC Alarm

Dietary supplement firms could face more aggressive enforcement from the Federal Trade Commission as they take advantage of increased direct response marketing opportunities created by the recession

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts